Publications by authors named "Peter Lassota"

Claim this Profile
E
Evaluation of the mTOR inhibitor, everolimus, in combination with cytotoxic antitumor agents using human tumor models in vitro and in vivo.
Terry O'Reilly, Paul M J McSheehy, Markus Wartmann, Peter Lassota, Ralf Brandt

Anticancer Drugs· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-invasive detection of a small number of bioluminescent cancer cells in vivo.
Jae-Beom Kim, Konnie Urban, Edward Cochran, Steve Lee, Angel Ang, Peter Lassota

PLoS One· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A spontaneous acinar cell carcinoma model for monitoring progression of pancreatic lesions and response to treatment through noninvasive bioluminescence imaging.
Ning Zhang, Scott Lyons, Ed Lim, Peter Lassota

Clin Cancer Res· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
0
07H239-A, a new cytotoxic eremophilane sesquiterpene from the marine-derived Xylariaceous fungus LL-07H239.
Leonard A McDonald, Laurel R Barbieri, Valerie S Bernan, Jeffrey Janso, Peter Lassota

J Nat Prod· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioluminescent imaging of Cdk2 inhibition in vivo.
Guo-Jun Zhang, Michal Safran, Wenyi Wei, Erik Sorensen, Peter Lassota

Nat Med· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective growth inhibition of tumor cells by a novel histone deacetylase inhibitor, NVP-LAQ824.
Peter Atadja, Lin Gao, Paul Kwon, Nancy Trogani, Heather Walker, Peter Lassota

Cancer Res· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N-hydroxy-3-phenyl-2-propenamides as novel inhibitors of human histone deacetylase with in vivo antitumor activity: discovery of (2E)-N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2-propenamide (NVP-LAQ824).
Stacy W Remiszewski, Lidia C Sambucetti, Kenneth W Bair, John Bontempo, David Cesarz, Peter Lassota

J Med Chem· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of tubulin polymerization by vitilevuamide, a bicyclic marine peptide, at a site distinct from colchicine, the vinca alkaloids, and dolastatin 10.
Michael C Edler, Annette M Fernandez, Peter Lassota, Chris M Ireland, Louis R Barrows

Biochem Pharmacol· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis